Epidemiological Profile of Meningococcal Disease in the United States
Open Access
- 1 March 2010
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 50 (s2) , S37-S44
- https://doi.org/10.1086/648963
Abstract
Neisseria meningitidis is a leading cause of bacterial meningitis and other serious infections worldwide. The epidemiological profile of N. meningitiKeywords
This publication has 89 references indexed in Scilit:
- Summary of notifiable diseases--United States, 2006.2008
- Risk Factors for Meningococcal Disease in Students in Grades 9–12The Pediatric Infectious Disease Journal, 2008
- Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd ImmunityThe Journal of Infectious Diseases, 2008
- A Multivalent Conjugate Vaccine for Prevention of Meningococcal Disease in InfantsPublished by American Medical Association (AMA) ,2008
- Immunogenicity of a Tetravalent Meningococcal Glycoconjugate Vaccine in InfantsJAMA, 2008
- A novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus-toxoid conjugate vaccine is immunogenic and induces immune memory when co-administered with DTPa-HBV-IPV and conjugate pneumococcal vaccines in infantsVaccine, 2007
- Incidence of Pneumococcal Disease Due to Non–Pneumococcal Conjugate Vaccine (PCV7) Serotypes in the United States during the Era of Widespread PCV7 Vaccination, 1998–2004The Journal of Infectious Diseases, 2007
- The outbreak of meningitis due to Neisseria meningitidis W135 in 2003 in Burkina Faso and the national response: Main lessons learntVaccine, 2007
- Meningococcal Meningitis: Unprecedented Incidence of Serogroup X--Related Cases in 2006 in NigerClinical Infectious Diseases, 2007
- Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccinesFEMS Microbiology Reviews, 2007